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Introduction: Neurocognitive impairments have been observed in patients with bipolar 
disorder (BD) even during the euthymic phase of the disease, potentially representing trait-
associated rather than state-associated characteristics of the disorder. In the present study, we 
used transcranial direct current stimulation (tDCS) applied to cerebellar and prefrontal cortices 
to improve the neurophysiological performances of patients with euthymic BD.
Methods: Twenty-five outpatients with BD underwent open-label prefrontocerebellar tDCS 
for 3 consecutive weeks. Neurophysiological performances were assessed through the exami-
nation of the P3b and P3a subcomponents of P300 event-related potential at baseline and after 
stimulation.
Results: Compared to baseline, P3b component after tDCS showed significantly higher ampli-
tude and shorter latency (latency: Fz P=0.02, Cz P=0.03, and Pz P=0.04; amplitude: Fz P=0.24, 
Cz P=0.02, and Pz P=0.35).
Conclusion: In our sample of patients with euthymic BD, concomitant prefrontoexcitatory and 
cerebellar-inhibitory modulations led to improved brain information processing stream. This 
improvement may at least partially result from neuroplastic modulation of prefrontocerebellar 
circuitry activity.
Keywords: mood disorders, tDCS, cerebellum, P300, dorsolateral prefrontal cortex, event-
related potentials
Introduction
Bipolar disorder (BD) is a severe and disabling disease. The course of BD has traditionally 
been viewed as episodic, that is with symptomatic and functional recovery between mood 
episodes.1 This view has recently been challenged by evidence documenting how, despite 
symptomatic improvements or recovery following mood episodes, many individuals with 
BD experience difficulties in daily functioning (eg, there are higher rates of unemployment 
and disability among individuals with BD than in the normal population).2–7
Cognitive and functional impairments have been observed in patients with BD 
even during the euthymic phase of the disease, potentially representing trait-associated 
rather than state-associated characteristics of the disorder.2–7 From a neurophysiologi-
cal point of view, event-related potentials (ERPs) allow the identification of specific 
neurocognitive deficiencies.8–10 In particular, the P300 component has been studied 
widely, and it is believed to be related to stimuli categorization as an indicator of selec-
tive attention and memory updating.8 The P300 consists of two main subcomponents, 
namely P3a and P3b.8,10 The P3a is elicited by a distracter stimulus, and it has been 
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interpreted as a neural correlate of the orienting response; 
the P3b component, which is elicited by a target rare stimu-
lus, reflects neuronal activity associated with revision of 
the mental representation of the previous event within the 
stimulus environment.8
Recent studies hypothesized that trait-associated neu-
rocognitive impairments in patients with BD could be 
related to prefrontocerebellum circuitry dysfunctions and, in 
particular, to the loss of the physiological inverse metabolic 
activity between dorsolateral prefrontal cortex (hypoactiv-
ity) and subcortical areas, such as thalamus and cerebellum 
(hyperactivity).11–16 Therefore, the aim of this preliminary 
study was to improve the brain information processing stream 
(assessed through P300 ERP) stimulating cerebellar and pre-
frontal cortices with transcranial direct current stimulation 
(tDCS), a form of neuromodulation that uses constant, low 
current delivered to the brain area of interest via inhibitory 
(cathodal) and excitatory (anodal) electrodes.17,18
Methods
Participants and study design
The sample consisted of 27 outpatients (ten males and 
17 females; mean age: 45.9±12.8) with a diagnosis of BD 
type I (n=16) or II (n=11) in the euthymic phase of the disease 
defined by Hamilton Depression Rating Scale 7 and Young 
Mania Rating Scale 7 (disease duration: 18.01±11.09 years). 
Diagnoses were made through the Structured Clinical 
Interview for Diagnostic and Statistical Manual of Men-
tal Disorders fourth edition Axis I disorders.19,20 Patients 
were consecutively recruited at the Policlinico Umberto I 
University Hospital of Rome. Patients were screened and 
excluded for having significant concomitant neurological or 
organic diseases, comorbid Axis I diagnoses, left handed-
ness, pharmacological treatment with typical antipsychotics, 
or hospitalization in the last 12 months. All patients were 
on stable pharmacological treatment with lithium (n=13), 
anticonvulsants (n=18), atypical antipsychotics (n=18), 
benzodiazepines (n=11), and/or antidepressants (n=6) for at 
least 2 months. The tDCS was applied to patients in addi-
tion to the standard pharmacological maintenance therapies, 
which remained unchanged along the intervention. These 
participants had previously been enrolled in our research 
in other studies with different aims and objectives.13,14,21 
The research protocol was approved by the institutional 
review board of Policlinico Umberto I University Hospital 
and Sapienza University of Rome, in accordance with the 
Declaration of Helsinki, 1975. All patients signed a written 
informed consent before the tDCS treatment.
Transcranial direct current stimulation
The tDCS is a brain modulation technique using constant, 
low current delivered directly to the brain area of interest via 
inhibitory (cathodal) and excitatory (anodal) electrodes.17,18 
In our study, tDCS electrode montage was as follows: cathodal 
tDCS on the right cerebellar cortex, 1 cm below and 4 cm 
lateral to the inion, and anodal tDCS over the left dorsolateral 
prefrontal cortex (ie, at Fp1 according to the International 
10/20 System for EEG electrodes). The intensity of stimula-
tion was set at 2 mA and delivered for 20 minutes every work-
ing day (Monday to Friday) for 3 consecutive weeks. More 
details can be found in previously published articles.13,14
Neurophysiological evaluation
Neurophysiological evaluation consisted of an ERP evalu-
ation with a P300 Novelty Task. The electroencephalogram 
signals were recorded with F3, Fz, F4, C3, Cz, C4, P3, Pz, and 
P4 scalp electrodes, according to the International 10–20 Sys-
tem. The P300 Novelty Task consisted of a sequence of three 
tones (standard, target, and novel). The standard stimulus 
was 1,000 Hz tone (duration: 200 ms; rise–fall times: 10 ms; 
intensity: 80 dB sound pressure level (SPL); and probability 
of occurrence: 0.8), whereas the infrequent target stimulus 
was 2,000 Hz tone (duration: 200 ms; rise–fall times: 10 ms; 
intensity: 80 dB SPL; and probability of occurrence: 0.1). The 
novel sounds (probability of occurrence: 0.1) were unique, 
nonrepeating sound effects (novels) either sampled from a 
sound effects compact disk or generated in the laboratory 
using a microphone as recordings of typical environmental 
sounds (eg, a key in a lock and a cup being placed on a 
table).21,22 These novel sounds were clipped to a length of 
200 ms and were unidentifiable and ambiguous. The intensi-
ties of all stimuli including novel sounds were checked using 
a calibrated sound-level meter (Radio Shack 33-2055) and 
adjusted so the perceived intensity by the subject was 80 dB. 
The subjects were not informed that the novel sounds would 
be presented, and if they asked questions about their presence, 
they were reminded to count only to the target tones. The 
interstimulus interval varied randomly between 2 seconds 
and 3 seconds. The task lasted for ∼15 minutes.
The ERPs were measured as grand averaged wave-
forms. Trials containing eye movements were automatically 
rejected. A further selection was performed in the offline 
analysis to reject other kinds of artifacts, according to the 
clinical guidelines.23 For each subject, all artifact-free trials 
were averaged per stimulus (target and novel) and filtered 
with a low-pass digital filter of 20 Hz, for each stimulus. 
Scalp electrode activity was measured at all electrode sites 
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of which Fz, Cz, and Pz were analyzed. Fz, Cz, and Pz were 
chosen for analyses because ERPs responses are largest on 
the midline locations.
The P3b and P3a components were identified as the 
largest positive deflections between 250 ms and 500 ms, 
respectively, in the target and novel responses. The amplitude 
of these components was identified by means of baseline to 
peak measurements.24
statistical analysis
The Statistical Package for the Social Sciences (SPSS) was 
used for statistical calculations. All tests were two tailed 
with an alpha =0.05. Raw data were normally distributed 
and are reported in Table 1 as mean ± standard deviation. 
Paired sample t-test was used to compare pretreatment and 
posttreatment measures.
Results
Two patients did not complete the stimulation protocol 
because of the onset of migraine. The remaining 25 patients 
tolerated tDCS without complications with the exception 
of three patients complaining of a transient burning sensa-
tion delimited to the electrode site. All patients correctly 
performed required tasks during each ERPs recording. 
Grand averaged waveforms for target stimulus at T0 and T1 
are shown in Figure 1. Measurements of P3b components 
revealed a significant higher amplitude and shorter latency 
after tDCS treatment than baseline evaluation (latency: Fz 
P=0.02, Cz P=0.03, and Pz P=0.04; amplitude: Fz P=0.24, 
Cz P=0.02, and Pz P=0.35; Table 1; Figure 1). No significant 
differences were observed in P3a latency and amplitude in 
the two ERP sessions (Table 1).
Discussion
To the best of our knowledge, this is the first study inves-
tigating prefrontocerebellar tDCS potential in improving 
P300 performances on patients with euthymic BD. Our 
data showed that tDCS led to significant changes (larger 
amplitude and shorter latency) in the P3b parameters after 
stimulation, whereas the P3a component did not show any 
significant change.
The P300 is the most widely used and studied ERP com-
ponent in psychiatry.25 This component reflects cognitive 
Figure 1 grand averaged P3b and P3a traces at mid-line scalp sites at T0 (pre-tDcs: thin line) and T1 (post-tDcs: thick line), respectively, for target and novel stimuli.
Note: The analysis time was 800 ms with a 100 ms prestimulus baseline.
Abbreviation: tDcs, transcranial direct current stimulation.
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Table 1 Mean scores of P3 components assessments at pre-
tDcs and post-tDcs evaluations
Event-related potential Pre-tDCS  
evaluation
Post-tDCS  
evaluation
P-value
Target lat (ms) P3b Fz 384.8±48.4 358.7±20.4 0.02*
cz 384.8±46.5 361.3±20.3 0.03*
Pz 390.1±45.1 366.3±28.5 0.04*
amp (µV) P3b Fz 4.7±3.9 6.5±6.1 0.24
cz 6.4±4.5 9.8±4.8 0.02*
Pz 9.2±6.1 11.1±5.9 0.35
Novel lat (ms) P3a Fz 332.2±28.4 316.4±35.7 0.11
cz 329.4±32.7 330.9±42.2 0.88
Pz 342.4±26.1 336.4±46.7 0.62
amp (µV) P3a Fz 6.4±4.2 4.7±4.3 0.20
cz 8.5±4.5 8.5±5.3 0.98
Pz 9.9±4.3 9.9±4.7 0.99
Notes: *P0.05. Data are presented as mean ± standard deviation.
Abbreviations: tDcs, transcranial direct current stimulation; lat, latency; amp, 
amplitude.
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processes involved in stimulus categorization as an indicator 
of selective attention and memory updating.8–10 In particular, 
although the P3a, elicited by distracter stimulus, is related to 
an orienting response during a context-updating process, the 
P3b component is associated with task-relevant attentional 
mechanisms and decision-making processes.8 Our findings 
suggest an improvement in the context-updating function 
(as revealed by the significant changes in P3b), whereas 
the orienting phase of the stimulus processing was not sig-
nificantly influenced by the treatment (as revealed by the 
nonsignificant changes in P3a).
The results of the present research preliminarily indicate 
that concomitant prefrontal excitatory and cerebellar inhibi-
tory tDCS stimulation may have a positive effect on brain 
global information processing stream. It is thus possible to 
hypothesize that the observed functional improvements may 
be at least partially attributable to functional modulation of 
prefrontocerebellar circuitry activity, as suggested in the 
previous studies.11–16
From a clinical point of view, cognitive disturbances 
have gained considerable importance as critical features of 
psychiatric disorders, and it is now believed that they might 
represent valid therapeutic targets.9,26 It is currently accepted 
that cognitive impairment and symptomatic manifestations 
of mental disorders may require separate and integrated 
therapeutic approaches.9,26 As improvements in P300 perfor-
mances have been associated with improvements in cognitive 
functioning,9 it might be hypothesized that the proposed 
prefrontocerebellar tDCS protocol could potentially be used 
as a complementary therapeutic approach with possible posi-
tive clinical outcomes.
The small sample size and the open-label design are 
major limitations of the study. Moreover, we assessed a 
relatively large number measures and we did not correct for 
multiple comparisons; therefore, these results should only be 
considered as preliminary/hypothesis generating. Among the 
strengths 1) this is one of the few studies using concomitant 
prefrontal-excitatory and cerebellar-inhibitory tDCS, as well 
as the first study to assess the effects of such stimulation 
through P300, 2) the sample was clinically well characterized, 
3) P300 is a reliable marker of neurocognitive processes, and 
4) during tDCS administration, patients’ pharmacological 
maintenance therapies remained unchanged, allowing us to 
specifically account for tDCS effect on P300.
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